Antenatal tocolytic exposure and postnatal patent ductus arteriosus outcomes in preterm infants born at ≤32 weeks: a retrospective cohort study
{{output}}
Objectives: The impact of antenatal tocolytic therapy on postnatal patent ductus arteriosus (PDA) outcomes in preterm infants remains unclear. Previous studies have rarely evaluated clinically significant treatment-requiring PDA ... ...
